Evaluation of the AMPLICOR Cytomegalovirus Test with Specimens from Human Immunodeficiency Virus-Infected Subjects
- 1 September 1998
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 36 (9) , 2509-2513
- https://doi.org/10.1128/jcm.36.9.2509-2513.1998
Abstract
The AMPLICOR cytomegalovirus (CMV) test, a new qualitative assay for the detection of CMV DNA in plasma, was compared to conventional methods and quantitative PCR (Q-PCR) assays by using leukocytes and plasma from 179 blood samples from subjects with AIDS. For the diagnosis of CMV disease, cell-based assays such as a Q-PCR with polymorphonuclear leukocytes (Q-PCR-PMNL) and a pp65 antigenemia assay had the highest sensitivities but suffered from a lack of specificity. The best agreement between the results of the Q-PCR-PMNL assay and those of the AMPLICOR test was found when a threshold diagnostic value of 690 copies per 10 5 cells was selected for the Q-PCR-PMNL assay. In that context, the AMPLICOR CMV test had a sensitivity of 96.4% and a specificity of 95.3% when results were compared to results of the cell-based PCR assay. This threshold was close to the one described as associated with the best sensitivity and specificity for the diagnosis of CMV disease in a recently published study (4). Blood samples that tested positive by the Q-PCR-PMNL assay but negative by the AMPLICOR CMV test were associated with viral loads (mean, 785 copies, median, 96 copies per 10 5 leukocytes) lower than the viral loads of blood samples that tested positive by both assays (mean, 21,452 copies; median, 9,784 copies per 10 5 leukocytes) ( P = 0.003). The AMPLICOR CMV test gave positive results at least 48 days before the development of symptomatic CMV disease in a longitudinal analysis of a limited subset of patients ( n = 6) from whom sequential specimens were available for testing. In conclusion, the AMPLICOR CMV test is a very convenient assay combining rapidity, simplicity, and the possibility of batch testing. A positive result by this test seems particularly important since this implies, in most instances, the presence or the imminence of CMV disease, although a negative test result does not rule out disease.Keywords
This publication has 31 references indexed in Scilit:
- A case of ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with AIDSAIDS, 1997
- Utility of Urine and Leukocyte Cultures and Plasma DNA Polymerase Chain Reaction for Identification of AIDS Patients at Risk for Developing Human Cytomegalovirus DiseaseThe Journal of Infectious Diseases, 1997
- Detection of Ganciclovir Resistance Mutations and Quantitation of Cytomegalovirus (CMV) DNA in Leukocytes of Patients with Fatal Disseminated CMV DiseaseThe Journal of Infectious Diseases, 1996
- Quantitation Of Human Cytomegalovirus DNA From Peripheral Blood Cells Of Human Immunodeficiency Virus-Infected Patients Could Predict Cytomegalovirus RetinitisThe Journal of Infectious Diseases, 1995
- Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. The Italian Foscarnet Study GroupAntimicrobial Agents and Chemotherapy, 1994
- Incidence and Natural History of Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Disease Treated with ZidovudineThe Journal of Infectious Diseases, 1992
- High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients.Journal of Clinical Investigation, 1992
- Cytomegalovirus Infection in Patients with AIDSClinical Infectious Diseases, 1992
- Predictive value of cytomegalovirus viraemia for the occurrence of CMV organ involvement in AIDSJournal of Medical Virology, 1990
- Human cytomegalovirus viraemia in HIV-1-seropositive patients at various clinical stages of infectionAIDS, 1990